Strive, Inc. Files 8-K with Financials

TL;DR

Strive, Inc. dropped an 8-K on 9/22/25 with financials and disclosures.

AI Summary

Strive, Inc. filed an 8-K on September 22, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Asset Entities Inc. until March 30, 2022, is incorporated in Nevada and headquartered in Dallas, Texas.

Why It Matters

This filing provides updated financial information and disclosures for Strive, Inc., which is important for investors to assess the company's current financial health and regulatory compliance.

Risk Assessment

Risk Level: low — This is a routine filing of an 8-K, which typically contains standard disclosures and financial information without immediate, significant operational changes.

Key Players & Entities

• Strive, Inc. (company) — Filer
• Asset Entities Inc. (company) — Former company name
• Nevada (jurisdiction) — State of incorporation
• Dallas, TX (location) — Principal executive offices
• September 22, 2025 (date) — Date of report

FAQ

Key Financial Figures

• $0.001 — hich registered Class A Common Stock, $0.001 par value per share ASST The Nasdaq

Filing Documents

• dp234646_8k.htm (8-K) — 45KB
• dp234646_ex9901.htm (EX-99.1) — 40KB
• 0000950103-25-011928.txt ( ) — 264KB
• asst-20250922.xsd (EX-101.SCH) — 3KB
• asst-20250922_lab.xml (EX-101.LAB) — 33KB
• asst-20250922_pre.xml (EX-101.PRE) — 22KB
• dp234646_8k_htm.xml (XML) — 4KB

01

Item 7.01 Regulation FD Disclosure On September 22, 2025, Strive, Inc. ("Strive") and Semler Scientific, Inc., a Delaware corporation ("Semler Scientific"), issued a joint press release announcing that they had entered into an Agreement and Plan of Merger, pursuant to which, among other things, a newly formed subsidiary of Strive will be merged with and into Semler Scientific (the "Merger"), with Semler Scientific surviving the Merger as a wholly owned subsidiary of Strive. A copy of the press release is attached hereto as Exhibit 99.1. The information furnished pursuant to this Item 7.01 (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Exchange Act or the Securities Act, except as expressly set forth by specific reference in such a filing. Cautionary Statement Regarding Forward-Looking Certain statements herein and the documents incorporated herein by reference may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the " Securities Act "), and Rule 175 promulgated thereunder, and Section 21E of the Exchange Act and Rule 3b-6 promulgated thereunder, which statements involve inherent risks and uncertainties. Examples of forward-looking statements include, but are not limited to, statements regarding the outlook and expectations of Strive and Semler Scientific, respectively, with respect to the proposed transaction, the strategic benefits and financial benefits of the proposed transaction, including the expected impact of the proposed transaction on the combined company's future financial performance, the timing of the closing of the proposed transaction, and the ability to successfully integrate the

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Joint Press Release, dated September 22, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 22, 2025 STRIVE, INC. /s/ Matthew Cole Name: Matthew Cole Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR